These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2510585)

  • 21. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Ann Neurol; 1993 Jun; 33(6):646-9. PubMed ID: 8098933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals].
    Kamihira S; Sohda H; Momita S; Amagasaki T; Yamada Y; Ikeda S; Tomonaga M; Ichimaru M; Kinosita K; Sawada T
    Rinsho Ketsueki; 1989 Jun; 30(6):823-9. PubMed ID: 2795893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups].
    Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O
    Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of myasthenia gravis occurring in the period of remission of chronic inflammatory demyelinating polyradiculoneuropathy].
    Inatus A; Ohi T; Shioya K; Matsukura S
    Rinsho Shinkeigaku; 1992 Aug; 32(8):878-9. PubMed ID: 1490316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of human T lymphotropic virus type I in !Kung San in Bushmanland, Namibia.
    Steele AD; Bos P; Joubert JJ; Evans AC; Joseph S; Tucker L; Aspinall S; Lecatsas G
    Am J Trop Med Hyg; 1994 Oct; 51(4):460-5. PubMed ID: 7943573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of IgG and IgG1 anti-HTLV-1 reactivity by an indirect immunofluorescence flow cytometric assay for the identification of persons infected with HTLV-1, asymptomatic carriers and patients with myelopathy.
    Coelho-dos-Reis JG; Martins-Filho OA; de Brito-Melo GE; Gallego S; Carneiro-Proietti AB; Souza JG; ; Barbosa-Stancioli EF
    J Virol Methods; 2009 Sep; 160(1-2):138-48. PubMed ID: 19447144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation-related transmission of human T lymphotropic virus type I (HTLV-I).
    Kikuchi H; Ohtsuka E; Ono K; Nakayama T; Saburi Y; Tezono K; Ogata M; Iwahashi M; Nasu M
    Bone Marrow Transplant; 2000 Dec; 26(11):1235-7. PubMed ID: 11149739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K; Tebbe B; Finckh U; Rolfs A
    Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLVI antibodies in multiple sclerosis and other neurological diseases.
    Ferrante P; Seresella M; Cocuzza CE; Caputo D; Cattaneo E; Achilli G; Cazzullo CL
    Acta Neurol (Napoli); 1990 Feb; 12(1):95-9. PubMed ID: 2337003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurologic diseases associated with the HTLV-1 virus in Panama].
    Gracia F; Castillo L; de Lao SL; Archibold CA; Larreátegui M; Reeves WC; Levine P
    Rev Med Panama; 1990 Sep; 15(3):197-203. PubMed ID: 2284449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of different methods for anti-HTLV-I assay].
    Goto H; Kawahata S; Ishi K; Igari J
    Rinsho Byori; 1992 Sep; 40(9):965-9. PubMed ID: 1434033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthetic glucocorticoid therapy of patients with neurological diseases and selection of the therapeutic schedule].
    Takatsu M
    Nihon Rinsho; 1994 Mar; 52(3):698-705. PubMed ID: 8164370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum antibodies to HTLV-I in human demyelinating disease.
    Epstein L; Blumberg B; Crowley J; Samuel K; Goudsmit J; Cook S; Dowling P
    Acta Neurol Scand; 1987 Apr; 75(4):231-3. PubMed ID: 2884798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin classes of antibody for human T-lymphotropic virus type-I (HTLV-I) in healthy donors and HTLV-I-associated disorders.
    Kamihira S; Sohda H; Oyakawa N; Moriuti Y; Momita S; Ikeda S; Yamada Y; Ichimaru M; Kinosita K; Okuda H
    Vox Sang; 1989; 56(3):168-73. PubMed ID: 2728394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for (anti-human T-cell leukemia virus type I) IgG in serum using recombinant gag p24(14-214) as antigen.
    Kohno T; Hirota K; Sakoda I; Yamasaki M; Yokoo Y; Ishikawa E
    J Clin Lab Anal; 1992; 6(5):302-10. PubMed ID: 1403350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody profile of early HTLV-I infection.
    Chen YM; Gomez-Lucia E; Okayama A; Tachibana N; Lee TH; Mueller N; Essex M
    Lancet; 1990 Nov; 336(8725):1214-6. PubMed ID: 1978071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibodies to HTLV-I in Thai patients with chronic progressive myelopathy, multiple sclerosis, myopathy and in HIV-seropositive intravenous drug abusers.
    Hemachudha T; Phanuphak P; Sirivichayakul S; Phanthumchinda K
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):33-5. PubMed ID: 2751768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.